|

Iohexol 300 Mg/mL Injectable Solution Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Omnipaque 300

Pipeline

Phase 1: 1

Top Sponsors

  • Kalie Tommerdahl1

Indications

  • Diabetic Kidney Disease1
  • Insulin Sensitivity1
  • Type 1 Diabetes1
  • Endothelial Dysfunction1
  • Cardiovascular Diseases1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.